At the highest weekly 12mg dose, participants lost an average of 24.2% of their starting body weight over 48 weeks
The index events only include events that occurred up to 20 years ago
Research on GLP-1 medications consistently shows that patients who combine pharmacotherapy with lifestyle interventions achieve better outcomes and are better positioned to maintain those results over time
Some users report experiencing anhedonia (a lack of pleasure in previously enjoyable activities), as their brain's normal pathways for reward and satisfaction are disrupted
Severe signs requiring medical attention include persistent vomiting or diarrhea, confusion, rapid heart rate, and significant lightheadedness when standing
However, as more people use the drug, the possibility of occurrence of rare adverse events also increases